BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23271367)

  • 1. IL-6 receptor is a possible target against growth of metastasized lung tumor cells in the brain.
    Noda M; Yamakawa Y; Matsunaga N; Naoe S; Jodoi T; Yamafuji M; Akimoto N; Teramoto N; Fujita K; Ohdo S; Iguchi H
    Int J Mol Sci; 2012 Dec; 14(1):515-26. PubMed ID: 23271367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis.
    Seike T; Fujita K; Yamakawa Y; Kido MA; Takiguchi S; Teramoto N; Iguchi H; Noda M
    Clin Exp Metastasis; 2011 Jan; 28(1):13-25. PubMed ID: 20953899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling.
    Hashizume M; Mihara M
    Rheumatol Int; 2009 Feb; 29(4):397-401. PubMed ID: 18802703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family.
    Mihara M; Kasutani K; Okazaki M; Nakamura A; Kawai S; Sugimoto M; Matsumoto Y; Ohsugi Y
    Int Immunopharmacol; 2005 Nov; 5(12):1731-40. PubMed ID: 16102523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression.
    Oguro T; Ishibashi K; Sugino T; Hashimoto K; Tomita S; Takahashi N; Yanagida T; Haga N; Aikawa K; Suzutani T; Yamaguchi O; Kojima Y
    Eur J Cancer; 2013 May; 49(7):1715-24. PubMed ID: 23274199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells.
    Sierra A; Price JE; García-Ramirez M; Méndez O; López L; Fabra A
    Lab Invest; 1997 Oct; 77(4):357-68. PubMed ID: 9354770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 receptor inhibitor suppresses bone metastases in a breast cancer cell line.
    Wakabayashi H; Hamaguchi T; Nagao N; Kato S; Iino T; Nakamura T; Sudo A
    Breast Cancer; 2018 Sep; 25(5):566-574. PubMed ID: 29557068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
    Weng YS; Tseng HY; Chen YA; Shen PC; Al Haq AT; Chen LM; Tung YC; Hsu HL
    Mol Cancer; 2019 Mar; 18(1):42. PubMed ID: 30885232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Insights into Interleukin 6 (IL-6) Cis- and Trans-signaling Pathways by Differentially Manipulating the Assembly of the IL-6 Signaling Complex.
    Lacroix M; Rousseau F; Guilhot F; Malinge P; Magistrelli G; Herren S; Jones SA; Jones GW; Scheller J; Lissilaa R; Kosco-Vilbois M; Johnson Z; Buatois V; Ferlin W
    J Biol Chem; 2015 Nov; 290(45):26943-26953. PubMed ID: 26363066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow stromal cells reduce ischemia-induced astrocytic activation in vitro.
    Gao Q; Li Y; Shen L; Zhang J; Zheng X; Qu R; Liu Z; Chopp M
    Neuroscience; 2008 Mar; 152(3):646-55. PubMed ID: 18313231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary.
    Yanaihara N; Hirata Y; Yamaguchi N; Noguchi Y; Saito M; Nagata C; Takakura S; Yamada K; Okamoto A
    Mol Carcinog; 2016 May; 55(5):832-41. PubMed ID: 25856562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple myeloma and B cell lymphoma. Investigation of IL-6, IL-6 receptor antagonist (IL-6RA), and GP130 antagonist (GP130A) using various parameters in an in vitro model.
    Kovacs E
    ScientificWorldJournal; 2006 Aug; 6():888-98. PubMed ID: 16892169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinoma.
    Shinriki S; Jono H; Ota K; Ueda M; Kudo M; Ota T; Oike Y; Endo M; Ibusuki M; Hiraki A; Nakayama H; Yoshitake Y; Shinohara M; Ando Y
    Clin Cancer Res; 2009 Sep; 15(17):5426-34. PubMed ID: 19706815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocilizumab does not block interleukin-6 (IL-6) signaling in murine cells.
    Lokau J; Kleinegger F; Garbers Y; Waetzig GH; Grötzinger J; Rose-John S; Haybaeck J; Garbers C
    PLoS One; 2020; 15(5):e0232612. PubMed ID: 32365119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teleost IL-6 promotes antibody production through STAT3 signaling via IL-6R and gp130.
    Kaneda M; Odaka T; Suetake H; Tahara D; Miyadai T
    Dev Comp Immunol; 2012 Oct; 38(2):224-31. PubMed ID: 22469658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of interleukin-6 receptor suppresses the proliferation of H460 lung cancer stem cells.
    Yi H; Cho HJ; Cho SM; Jo K; Park JA; Kim NH; Amidon GL; Kim JS; Shin HC
    Int J Oncol; 2012 Jul; 41(1):310-6. PubMed ID: 22552503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-trans retinoic acid modulates radiation-induced proliferation of lung fibroblasts via IL-6/IL-6R system.
    Tabata C; Kubo H; Tabata R; Wada M; Sakuma K; Ichikawa M; Fujita S; Mio T; Mishima M
    Am J Physiol Lung Cell Mol Physiol; 2006 Mar; 290(3):L597-606. PubMed ID: 16257998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of interleukin-6-transsignaling via gp130-Fc in hemorrhagic shock and sepsis.
    Mees ST; Toellner S; Marx K; Faendrich F; Kallen KJ; Schroeder J; Haier J; Kahlke V
    J Surg Res; 2009 Dec; 157(2):235-42. PubMed ID: 19589542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of cilia-localized Il-6R alpha by 17beta-estradiol in mouse and human fallopian tubes.
    Shao R; Nutu M; Karlsson-Lindahl L; Benrick A; Weijdegård B; Lager S; Egecioglu E; Fernandez-Rodriguez J; Gemzell-Danielsson K; Ohlsson C; Jansson JO; Billig H
    Am J Physiol Cell Physiol; 2009 Jul; 297(1):C140-51. PubMed ID: 19420002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas.
    Adachi Y; Aoki C; Yoshio-Hoshino N; Takayama K; Curiel DT; Nishimoto N
    Int J Cancer; 2006 Sep; 119(6):1303-11. PubMed ID: 16642474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.